Endovesical Bacillus Calmette-Guérin for Nonmuscle Invasive Bladder Cancer in Kidney Transplant Recipients: Is It Safe and Efficacious?

Exp Clin Transplant. 2022 Aug;20(8):789-791. doi: 10.6002/ect.2022.0154.
No abstract available

Publication types

  • Letter

MeSH terms

  • BCG Vaccine / adverse effects
  • Humans
  • Kidney Transplantation* / adverse effects
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local
  • Treatment Outcome
  • Urinary Bladder Neoplasms* / surgery

Substances

  • BCG Vaccine